Janux Therapeutics Growth Metrics (2021-2025) | JANX

Growth Metrics Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) -274073.00-34149.0055,557.00-1301.0030,980.0012,892.00-95830.0047,715.0013,559.00-46026.00160,750.00-377547.00400,466.00
EBITDA Margin Growth (3y) -314346.00-67283.00120,477.00-331134.0070,633.00
EBITDA Margin (QoQ) -68297.0035,572.007,991.00-9415.0021,409.00-21286.0040,272.00-27503.00-87313.00122,259.006,116.00-87087.00119,463.00-416038.00
EBIT Margin Growth (1y) -214864.00-25118.0056,724.00-5332.0019,274.00-13805.00-123306.0036,580.00-1367.00-62002.00180,756.00-753622.00781,195.00
EBIT Margin Growth (3y) -281446.00-100925.00114,174.00-722374.0064,153.00
EBIT Margin (QoQ) -69604.0035,637.0010,595.00-1746.0012,238.00-26419.0035,200.00-34824.00-97263.00133,467.00-2746.00-95459.00145,495.00-800911.00
EBT Margin Growth (1y) -223910.00-24287.0057,347.00800.0026,552.00-856.00-94231.0046,131.008,690.00-32642.00158,941.00-593198.00614,844.00
EBT Margin Growth (3y) -260793.00-57786.00122,057.00-546267.0067,777.00
EBT Margin (QoQ) -68650.0035,865.009,871.00-1373.0012,985.00-20682.0035,623.00-28782.00-80390.00119,679.00-1818.00-70114.00111,194.00-632459.00
Enterprise Value Growth (1y) 5,808.82%-72.20%10.57%-50.30%-19.67%25.50%-48.81%-31.72%583.14%689.42%1,383.79%1,079.12%-55.02%-75.69%-71.98%
Enterprise Value Growth (3y) 177.52%40.18%103.27%58.76%35.14%34.05%28.64%
Enterprise Value (QoQ) -63.21%118.83%-47.16%-34.66%46.34%-1.63%-14.61%2.09%-40.31%31.20%754.42%17.98%12.20%4.26%-67.41%-36.23%29.32%
FCF Margin Growth (1y) -220990.00100,877.00-32020.0019,650.008,768.00-117393.0039,501.006,776.00-50226.00135,498.00-3003.0038,441.00
FCF Margin Growth (3y) -262448.00118,983.004,478.0074,938.00
FCF Margin (QoQ) -272721.0074,486.00-12883.00-9872.0049,146.00-58412.0038,787.00-20753.00-77015.0098,482.006,063.00-77756.00108,710.00-40019.00
Net Margin Growth (1y) -223910.00-24287.0057,347.00800.0026,552.00-856.00-94231.0046,131.008,690.00-32642.00158,941.00-593198.00614,844.00
Net Margin Growth (3y) -260793.00-57786.00122,057.00-546267.0067,777.00
Net Margin (QoQ) -68650.0035,865.009,871.00-1373.0012,985.00-20682.0035,623.00-28782.00-80390.00119,679.00-1818.00-70114.00111,194.00-632459.00
Operating Margin Growth (1y) -214864.00-25118.0056,724.00-5332.0019,274.00-13805.00-123306.0036,580.00-1367.00-62002.00180,756.00-753622.00781,195.00
Operating Margin Growth (3y) -281446.00-100925.00114,174.00-722374.0064,153.00
Operating Margin (QoQ) -69604.0035,637.0010,595.00-1746.0012,238.00-26419.0035,200.00-34824.00-97263.00133,467.00-2746.00-95459.00145,495.00-800911.00
Return on Assets Growth (1y) -11.00-9.00-7.00-5.00-1.002.008.0013.008.007.003.00-4.00-1.00
Return on Assets Growth (3y) -3.001.004.004.006.00
Return on Assets (QoQ) -3.00-3.00-3.00-1.00-1.00-2.00-1.002.002.005.004.00-2.001.000.00-3.000.00
Return on Capital Employed Growth (1y) -12.00-10.00-9.00-8.00-4.00-1.008.0014.009.008.003.00-4.00-2.00
Return on Capital Employed Growth (3y) -7.00-3.001.001.003.00
Return on Capital Employed (QoQ) -3.00-3.00-3.00-2.00-2.00-3.00-2.002.002.006.004.00-3.001.001.00-3.000.00
Return on Equity Growth (1y) -12.00-11.00-9.00-7.00-1.003.0010.0015.0010.009.003.00-4.00-1.00
Return on Equity Growth (3y) -4.001.004.005.008.00
Return on Equity (QoQ) -3.00-3.00-3.00-2.00-1.00-2.00-1.003.002.006.004.00-3.001.001.00-3.000.00
Return on Sales Growth (1y) 269.00166.00164.00-63.0079.0011.00-23.00581.00275.00-31.00
Return on Sales Growth (3y) 623.00323.00
Return on Sales (QoQ) 189.00-5.0094.00-9.0086.00-8.00-133.00133.0018.00-42.00472.00-173.00